Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Garcia Marino sold 166,000 Dianthus Therapeutics, Inc. shares (Form 4)
Traded Aug 7, 2026 · Filed Aug 7, 2026
On Aug 7, 2026, Garcia Marino (Director, CEO AND PRESIDENT) sold 166,000 Dianthus Therapeutics, Inc. shares at an average US$108.11 for US$17.9M under a trading plan, leaving 65,292 shares. Filed Aug 7, 2026 (Form 4).
- Sold
- 166,000 shares
- Price
- US$108.11 average (US$107.49 to US$110.76)
- Value
- US$17.9M
- Holding after
- 65,292 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO AND PRESIDENT
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | Option exercise | 40,000 | US$8.44 | 105,292 | Direct |
| Aug 7, 2026 | Common Stock | Option exercise | 126,000 | US$8.44 | 231,292 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 10,384 | US$107.49 | 220,908 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 23,907 | US$108.05 | 197,001 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 2,373 | US$109.10 | 194,628 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 2,536 | US$110.02 | 192,092 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 800 | US$110.76 | 191,292 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 104,091 | US$107.96 | 87,102 | Direct |
| Aug 7, 2026 | Common Stock | Sale | 21,909 | US$108.72 | 65,292 | Direct |